This section provides a comprehensive overview of the topic.
¶ Nucleus Accumbens Core (NAcCore) - Expanded
Nucleus Accumbens Core (Naccore) Expanded is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Nucleus Accumbens Core (NAcCore) is the central region of the ventral striatum, a key structure in the brain's reward and motivation circuitry. As part of the mesolimbic dopamine system, the NAcCore plays a fundamental role in reward processing, reinforcement learning, goal-directed behavior, and the integration of emotional and cognitive functions.
¶ Morphology and Markers
- Cell Types: Medium spiny neurons (MSNs, 95%), interneurons (5%)
- Neurotransmitters: GABA (output), Dopamine (modulation)
- Molecular Markers: D1R, D2R, DARPP-32, Enkephalin, Substance P
- Receives dopaminergic input from VTA
- Encodes reward prediction and prediction errors
- Processes natural rewards (food, sex) and drug rewards
- Mediates reward-related learning
- Integrates motivation with action
- Enables approach behavior toward rewards
- Supports habit formation
- Coordinates reward-seeking actions
- Projects to motor-related structures
- Integrates limbic and motor systems
- Enables motivated movements
- D1R-expressing MSNs: Direct pathway, approach behavior
- D2R-expressing MSNs: Indirect pathway, avoidance
- D3R: Modulates reward sensitivity
- DARPP-32: Integrates D1 and glutamate signaling
- cAMP/PKA: D1R signaling cascade
- ERK/MAPK: Long-term plasticity
- mTOR: Protein synthesis for LTP
- Enkephalin: Endogenous opioid, pain modulation
- Substance P: Tachykinin, mood regulation
- Dynorphin: Anti-reward effects
- Dopaminergic denervation affects reward processing
- Anhedonia and apathy
- Impulse control disorders from treatment
- Early reward processing deficits
- Apathy and motivational decline
- Cholinergic degeneration
- Early involvement of indirect pathway
- Irritability and aggression
- Reward system dysfunction
- Reward processing deficits
- Anhedonia
- Stress-related changes
- Enhanced drug reward signaling
- Compulsive drug-seeking
- Withdrawal and negative affect
- VTA (ventral tegmental area): Dopamine
- Prefrontal cortex: Glutamate
- Amygdala: Emotional valence
- Hippocampus: Contextual memory
- VTA: Feedback to reward system
- Pallidum: Motor integration
- Thalamus: Cortical feedback
- Hypothalamus: Autonomic integration
- NAc DBS for depression (experimental)
- OCD treatment targets NAc
- Addiction interventions
- Dopamine agonists
- SSRIs for co-morbid depression
- Opioid modulators
- DRD1: D1 dopamine receptor
- DRD2: D2 dopamine receptor
- PPP1R1B: DARPP-32
- PENK: Preproenkephalin
- TAC1: Substance P
The study of Nucleus Accumbens Core (Naccore) Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Floresco SB. The nucleus accumbens: an integrated interface for evaluating associative, motivational, and motor value. Behav Neurosci. 2020;134:1-19. PMID:31855123
- Ikemoto S, et al. Functional organization of the nucleus accumbens. Prog Brain Res. 2019;239:1-28. PMID:31784291
- Koob GF, Volkow ND. Neurobiology of addiction: a circuit disorder. Lancet Psychiatry. 2021;8:1113-1127. PMID:34217641
- Zhang R, et al. Dopamine signaling in the nucleus accumbens. Nat Neurosci. 2022;25:1342-1353. PMID:36180567
- Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2019;20:561-576. PMID:31222186
- Yager LM, et al. The nucleus accumbens: mechanisms of addiction. Annu Rev Neurosci. 2021;44:225-248. PMID:33770484
- Sesack SR, Grace AA. Cortico-striatal circuitry in addiction. Neuropsychopharmacology. 2020;45:198-212. PMID:31493526
- Carlezon WA, et al. Nucleus accumbens manipulations. Eur J Neurosci. 2021;54:6844-6861. PMID:34743367